Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
227.50    -0.50 (-0.22%)
Bid:
226.50
Ask:
227.50
Spread: 1.00 (0.442%)
Market Cap: £628.84m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Interim Management Statement

15 May 2009 07:00

RNS Number : 2986S
Morgan Crucible Co PLC
15 May 2009
Β 

ο»Ώ

Press Release

Interim Management Statement

Morgan Crucible Co PLC

15thΒ May 2009

The Morgan Crucible Company plc - Interim Management Statement

The Morgan Crucible Company plc ('Morgan Crucible'), the advanced materials company, is issuing today its 'Interim Management Statement' regarding current trading, financial performance and outlook for the half year 2009. This statement constitutes Morgan Crucible's Interim Management Statement forΒ the period from 5 January to 14 MayΒ 2009 as required by the UK Listing Authority's Disclosure and Transparency Rules.

Group revenues for theΒ first half of 2009Β are expected to beΒ close toΒ Β£500m

The businesses acquired in the past 12 months,Β andΒ NP Aerospace in particular, are performing well and have contributed c.Β£75m to Group revenues for the year to date through April

ForΒ the first four months of the yearΒ GroupΒ revenues, excluding the benefits of acquisitions, are broadly in line with the equivalent period last year with positive currency translation offsetting reduced end-market demand caused by the global economic downturn

As weΒ indicated in our AGM trading statement last month,Β we anticipate thatΒ end-marketΒ demandΒ willΒ continueΒ on a downward trend over the coming months.Β In response, weΒ haveΒ taken further decisive actionΒ on our cost base to mitigate the impact on margins.Β TheΒ Group's overall headcount, excluding acquisitions,Β has nowΒ been reduced byΒ over 1,200 employeesΒ since the summer of last year and a number of other cost reduction initiatives, such asΒ short timeΒ working,Β have beenΒ implemented across our sites

Operating profit margins before restructuring costs are expected to be in high single digits at the half year,Β with a greater proportionΒ of the benefits ofΒ our cost reduction initiatives anticipatedΒ in the second half of the yearΒ 

The recent announcement of a new 3 year multi-currency facility for Β£280mΒ leaves the Group with a strongΒ and supportiveΒ banking group going forward

Commenting on the year to date performance and outlook, Mark Robertshaw, Chief Executive Officer,Β said:

"Our expectation of revenuesΒ approachingΒ Β£500 million at the half year reflects the progress we continue to make in our strategy of improving the quality and resilience of our business and in reducing the Group's exposure to economically cyclical markets. However, as we noted in our AGM trading statement last month, our expectation remains that marketsΒ willΒ continue to deteriorate further before they improve. As a result, we have taken additional decisive actions to align our cost base to demandΒ includingΒ reducing headcount by a further 200Β employeesΒ in April.Β We believe these actionsΒ positionΒ usΒ asΒ a leaner and fitter business for when marketsΒ ultimatelyΒ recover.

I am delighted that we were able to announce last month the successful renewal of our banking facilities. We believe this successful refinancing signals a strong endorsement from our relationship banksΒ ofΒ the Group's financial position and its future prospects."Β 

Β 

Carbon

The Carbon division, excluding NP Aerospace, has experienced the most difficult overall trading conditions of the Group's divisions in the first half.Β Β Organic revenues in the first four months of the year have remained in line with the equivalent period in 2008 with the benefits of favourable currency translation offsetting lower market demand. However, first halfΒ margins have been impacted by a lower level ofΒ body armour sales comparedΒ toΒ H1 2008.Β Body armour revenues are expected toΒ beΒ c.$10m for the half year compared to c.$28m in the equivalent period last year. As we look to the second half of the year, we continue to pursue new body armour contract opportunities particularly in theΒ USΒ and theΒ UK.

Our NP Aerospace business is continuing to perform above expectations on the back of major contract winsΒ with the UK Ministry of Defence. The recently announcedΒ c.Β£30mΒ contract for Tactical Support VehiclesΒ (TSV) has reinforced an already strong order book which now provides good visibility well into 2010.

The remaining businesses in the Carbon division, excluding body armour,Β have seenΒ a c.15% reduction in revenuesΒ year to dateΒ to the end of AprilΒ on a constant currency basis.Β We have seen some stabilisation in demand in our ElectricalΒ Carbon business in recent weeksΒ butΒ the Seals and Bearings business continues to trend downwards in terms of orders and revenues.Β Demand from theΒ semi-conductorΒ and solar marketsΒ hasΒ beenΒ very subdued so far this year.

In response to the difficult trading conditions,Β the Carbon division has implemented a range of aggressive cost reduction plans in early 2009 including permanent headcount reductions and the extensive use of short time working.

Β 

Technical Ceramics

Revenues forΒ the first four months of 2009Β for the Technical Ceramics divisionΒ are up c.35% year on year helped by favourable currency translation and theΒ additionΒ of the businesses acquired from Carpenter Technology last year. On a constant currency organic basis,Β revenues are downΒ c.11% year on year.Β 

Order intake in the Technical Ceramics division has continued on a downward trend in H1 across a number of end markets and in particular in theΒ USAΒ andΒ Europe. Nevertheless, despite the much more difficult environment, the division continues to win new business particularly in the aerospace and medical markets. The strategic focus on these markets has helped to offset the continuing softness in markets such as construction and semi-conductor equipment manufacture.Β 

The businesses acquired from Carpenter Technology last year have continued to perform well with the synergy benefits coming through as expected.Β 

To protect bottom line margins, the divisionΒ has acted swiftly toΒ implement a wide range of cost reduction programmes and has further initiatives currently underway.Β 

Β 

Insulating Ceramics

In the first four months of 2009 the Thermal Ceramics business revenues were at a similar level to last year taking into account favourable currency translation.Β On a constant currency basis, the year on year reduction in revenueΒ thisΒ year is c.12%.Β Order books have continuedΒ on a downward trendΒ as the year has progressed and we expect this to continue over the coming months. End markets such as construction, automotive and iron and steel remain weak while the chemical and petroleum (CPI) sector which had remained fairly robustΒ isΒ nowΒ showingΒ someΒ signs of projects being deferred or cancelled.Β Regionally,Β our business has shown resilience in our Asian and Latin American markets while North America and particularlyΒ EuropeΒ continue to see demand deteriorating.

The Thermal business has implemented aΒ numberΒ of cost reduction programmes in the first four months of the year which includeΒ siteΒ andΒ production lineΒ rationalisations. Further cost reduction plans are in place to counteract continuing softening in demand, particularly inΒ Europe, as we focus on mitigating the impact to our profitability in the coming months.Β 

The Molten Metal Systems business, by far the smallest of the Group's divisions,Β has seenΒ difficult trading conditions throughout the first four months of the yearΒ notablyΒ in North America andΒ EuropeΒ with constant currency revenues down close to 25% compared to the equivalent period in 2008.Β The restructuring of this business in the last eighteen months has meant that our expanded manufacturing facility inΒ Aurangabad,Β IndiaΒ is now fully operational and our new green field site inΒ ChinaΒ has recently come on stream.Β This provides us with a much lower ongoing cost base leavingΒ the businessΒ operationallyΒ well placed to benefit as end-markets recover.

Β 

Financial Position

A major area of focus in the first four months of 2009 has been the refinancing of our bank syndication which we formally completed on the 1stΒ May. This provides the Group with a level of facilities (Β£280 million) commensurate with the previous arrangements and withΒ the same financial covenants. Upfront fees for the new facility were c.Β£3.5 million and the present overall coupon we are paying on this bank debt is c.5%. The other major tranche to our financing arrangements is our c.$400m US Private Placement long-term debt on which we pay a c.6% fixed coupon.

Given the challenging trading environment weΒ continue to manageΒ our cash and balance sheet position very tightly. We have significantly reduced capital expenditure spend to an anticipated c.Β£12m inΒ the first halfΒ and are actively targeting ongoing improvements to working capital.

Restructuring costs in 2009Β are expected to beΒ c.Β£15 million, a higher figure than previouslyΒ indicated, reflecting the increased level of actions we have taken andΒ plan toΒ takeΒ in the coming months. These costs will be weighted more to the first half while we will see benefits accruing from these actions coming through more in the second half of the yearΒ with an average payback time ofΒ just over one year.

The Group has recently settled a tax liability in theΒ USAΒ relating to a disputed position from the late 1990's. The settlement was c.Β£20 million and will be reflected in our cash flow in the first half of 2009. This tax liability was fully provided for in the Group's balance sheet which will therefore see some degree of net tax provision release at the half year.

Our expectation for the half year is that the actions taken on both our income statement and balance sheet will mean that our net debt/EBITDA ratio will be broadly in line with the 2008 year end positionΒ at 2.1 times.

Β 

Outlook

The Group continues to face a challenging economicΒ environmentΒ withΒ demandΒ remaining on a downward trend. However, in anticipation of conditions continuing to deteriorate before they improve,Β we have been taking decisive action on our operating cost base with theΒ benefits ofΒ our cost reduction initiativesΒ expected to have a greater impact in the second half of the year.Β We believe that these actionsΒ positionΒ the Group well to benefit as end marketsΒ ultimatelyΒ recover.

For further enquiries:

Β 

Mark Robertshaw Morgan Crucible 01753 837207

Kevin Dangerfield

Β 

Mike Smith Finsbury 020 7251 3801

Clare Strange

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSBRGDUSBBGGCS
Date   Source Headline
28th Jul 20257:00 amRNSTransaction in Own Shares
25th Jul 20257:00 amRNSTransaction in Own Shares
24th Jul 20257:00 amRNSTransaction in Own Shares
23rd Jul 20257:00 amRNSTransaction in Own Shares
22nd Jul 20257:00 amRNSTransaction in Own Shares
21st Jul 20257:00 amRNSTransaction in Own Shares
18th Jul 20257:00 amRNSTransaction in Own Shares
17th Jul 20257:00 amRNSTransaction in Own Shares
16th Jul 20257:00 amRNSTransaction in Own Shares
15th Jul 20257:00 amRNSTransaction in Own Shares
14th Jul 20257:00 amRNSTransaction in Own Shares
11th Jul 20257:00 amRNSTransaction in Own Shares
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
8th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20251:42 pmRNSTotal Voting Rights
1st Jul 20257:00 amRNSTransaction in Own Shares
30th Jun 20257:00 amRNSTransaction in Own Shares
27th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20257:00 amRNSTransaction in Own Shares
17th Jun 20257:00 amRNSTransaction in Own Shares
16th Jun 20259:00 amRNSHolding(s) in Company
16th Jun 20259:00 amRNSBlock listing Interim Review
16th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20257:00 amRNSTransaction in Own Shares
10th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20258:54 amRNSDirector Declaration
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20254:56 pmRNSDirector/PDMR Shareholding
2nd Jun 20251:37 pmRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20259:56 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.